Eritromisina including makrolida group, works by inhibiting bacterial protein synthesis, are bacteriostatic or bakterisid, depending on the types and levels of bacteria in the blood. Eritromisina effective against gram-positive bacteria such as S. aureus (both of which produce penisillinase or not), group A Streptococcus, Enterococcus, C. diphtheriae and Pneumococcus.
Also effective against gram-negative bacteria such as Neisseria, H. influenzae, B. pertussis, Brucella also against rickets, Treponema and M. pneumoniae. Cross-resistance can occur between different classes of antibiotics makrolida.
Composition:
Each film coated tablet contains eritromisina etilsuksinat, equivalent to 500 mg eritromisina.
Indications:
To prevent upper respiratory tract infections caused by bacteria, especially S. pyogenes (streptococcal group A beta-hemolytic).
Dosage:
Adults: four times a day 250-500 mg
Children - children: day 30-50 mg / kg body weight in 4 divided doses. Giving an empty stomach. For severe infection of 4 grams a day is divided into several doses. For infections due to group A streptococci, therapy must be at least 10 days.
Also effective against gram-negative bacteria such as Neisseria, H. influenzae, B. pertussis, Brucella also against rickets, Treponema and M. pneumoniae. Cross-resistance can occur between different classes of antibiotics makrolida.
Composition:
Each film coated tablet contains eritromisina etilsuksinat, equivalent to 500 mg eritromisina.
Indications:
To prevent upper respiratory tract infections caused by bacteria, especially S. pyogenes (streptococcal group A beta-hemolytic).
Dosage:
Adults: four times a day 250-500 mg
Children - children: day 30-50 mg / kg body weight in 4 divided doses. Giving an empty stomach. For severe infection of 4 grams a day is divided into several doses. For infections due to group A streptococci, therapy must be at least 10 days.
0 comments:
Post a Comment